Two human breast cancer cell lines of diering invasive and metastatic potential, MDA-MB-435 and MCF7, were examined using subtractive suppression hybridization in a search for any genes associated with metastasis. Of the 17 cDNAs identi®ed as being dierentially expressed genes, it was determined that syntenin was overexpressed in metastatic MDA-MB-435 cells. Expression analysis showed that the expression level of syntenin was well correlated with invasive and metastatic potential in various human breast and gastric cancer cell lines. Moreover, gastric tumor tissues exhibited a much higher syntenin mRNA expression than their normal counterparts. Syntenin-transfected MCF7 cells migrated more actively, and showed an increased invasion rate relative to vector-transfectants or parental MCF7 in vitro, without evidencing any eect on the adhesion to ®bronectin, type I collagen and laminin. Similarly, the forced expression of syntenin to human gastric cancer cell line Az521 increased its migratory and invasive potential in vitro. Syntenin-expressing MCF7 cells were associated with the appearance of numerous cell surface extensions and with pseudopodia formation on collagen I, suggesting that syntenin may be involved in the signaling cascade to actin-reorganization. Mutation study suggested that PDZ2 domain of syntenin could be an essential role in its stimulatory eect on the cell migration. This is the ®rst demonstration that syntenin, a PDZ motif-containing protein, can be overexpressed during the metastatic progression of human breast and gastric cancer cells and that it can function as a metastasis-inducing gene.
Introduction
Since it was ®rst recognized that tumors had the ability to invade adjacent tissues and spread to distant organs, extensive research has been performed, expanding the body of knowledge concerning this basic hallmark of malignancy. Such spread and distant settlement of tumor cells is the major cause of human cancer deaths (Sporn, 1996) . With their capability for invasion and metastasis cancer cells are able to escape the primary tumor mass and colonize new terrain in the body. It is now widely accepted that the stepwise malignant progression of human cancer is a consequence of multistage genetic alterations that have accumulated in cells (Yokota, 2000) . Thus, to understand the molecular mechanisms of tumor progression, it is essential to identify the genes whose alterations have accumulated during the progression of the cancer as well as whose expression is responsible for the acquisition of metastatic potential in cancer cells.
Various methods for comparing patterns of gene expression have been described in the literature (Byers et al., 2000) . Of these, subtractive suppression hybridization (SSH) represents a simple and ecient technique for generating cDNAs that are highly enriched for dierentially expressed genes of both high and low abundance (Diatchenko et al., 1996) . In the present study, we used SSH to identify metastasisrelated genes by comparing their dierential gene expression pro®les between metastatic MDA-MB-435 and non-metastatic MCF7 breast cancer cell lines. Nine and eight dierent genes were identi®ed as being overexpressed in MCF7 and MDA-MB-435 cells, respectively. Of these, we ®rstly identi®ed syntenin as an overexpressed gene in MDA-MB-435 cells.
Syntenin has two PDZ domains and interacts with the COOH termini of syndecans, class B ephrins, EphA7, pro-TGF-a, neurexins, neurofascin, and the anion exchanger AE2 (Grootjans et al., 1997 (Grootjans et al., , 2000 Cowan et al., 2000; Torres et al., 1998; Lin et al., 1999; FernandezLarrea et al., 1999; Koroll et al., 2001) . Syntenin has been reported to be a component of cell adhesion sites and of micro®laments (Zimmermann et al., 2001) , and it has also been identi®ed as a major structural component of apical early endosomes (Fialka et al., 1999) .
Here, we describe the overexpression of syntenin in metastatic human breast and gastric cancer cell lines, and its eect in enhancing the cell migration and invasion of a human breast cancer cell line MCF7 and of gastric cancer cell line Az521 cells in vitro. We also show that the overexpression of syntenin in MCF7 cells exhibited a more polarized distribution of F-actin with pseudopodia formation. Our results suggest that syntenin can be overexpressed in metastatic human breast and gastric cancer cells and can promote the invasion and possibly the metastasis of the cells.
Results

Identification of differentially expressed genes in MDA-MB-435 or MCF7
As an eort to understand the invasive and metastatic progression of cancer, we have used SSH to generate a pro®le of genes overexpressed in metastatic and nonmetastatic cancer cell line. SSH was performed between MDA-MB-435 (invasive/metastatic phenotype) and MCF7 (poorly invasive/non-metastatic phenotype) human breast cancer cell lines. To identify the candidate genes for metastasis-suppressible genes, MCF7 cDNA was used as a tester. About 800 subtracted cDNA clones were obtained after subtraction, and dierential screening was sequentially performed by colony hybridization. Thirty-six cDNA clones were identi®ed as overexpressed in MCF7 cells as compared to MDA-MB-435 cells. Nucleic acid homology searches revealed nine dierent genes, whose expressions were elevated in MCF7 cells con®rmed by Northern blot analysis (Table 1) . Of these, the expressions of three genes, such as keratin 18, estrogen receptor and desmoplakin, have been known to be inversely correlated with the metastatic progression of breast cancer and used as potential markers for distinguishing weakly malignant cells from malignant cells in breast cancer cells (Schaller et al., 1996; Sheikh et al., 1995; Davies et al., 1999) .
To identify metastasis-achievable genes, MDA-MB-435 cDNA was used as a tester. About 1200 subtracted cDNA clones were obtained after subtraction, and then, dierential screening revealed that 37 cDNA clones were overexpressed in MDA-MB-435 cells as compared to MCF7 cells. After sequencing and Northern blot analyses, eight dierent genes were ®nally identi®ed as overexpressed in MDA-MB-435 (Table 1) . Of these, the expressions of osteopontin, vimentin, lactate dehydrogenase and tenacin C have already known to be associated with enhanced malignancy of breast cancer (Tuck et al., 1999; Stover et al., 1994; Simu et al., 1978; Talts et al., 1999) . Interestingly, we identi®ed syntenin as an overexpressed gene in metastatic MDA-MB-435 cells. Therefore, we further investigated a possible role of syntenin in metastatic progression of cancer cells.
Expression analysis of syntenin in various human breast and gastric cancer cell lines
Firstly, we examined mRNA expression of syntenin by Northern blot analysis in several human breast cancer cell lines, which had been characterized the invasive and metastatic potential (Figure 1a, upper panel) . A unique 2.4 kb transcript of syntenin was mainly detected in MDA-MB-435 and MDA-MB-231, which had been known to the most highly invasive and metastatic cell lines (Price et al., 1990) . The moderate expression of syntenin was also observed in the highly invasive Hs578T cell line (Thompson et al., 1992) . In contrast, weak signals were detected in the poorly We extended this ®nding to another type of epithelial solid tumor. We chose gastric cancer, which is the most prevalent cancer in East Asia, including Korea and Japan (Whelan et al., 1990) . We examined the expression of syntenin mRNA and protein in various gastric cancer cell lines (Figure 1b) . Expression of syntenin mRNA and protein was elevated in SNU-5, -216, -620 and -638 cells, which are established from secondary tumor sites and metastatic (Park et al., 1990 (Park et al., , 1997 , compared with SNU-1, -484 and Az-521 cells, which are from the primary tumor and poorly metastatic (Park et al., 1990 (Park et al., , 1997 Yasoshima et al., 1996) . Also, we analysed the mRNA expression of syntenin in gastric tumor tissues by Northern blot analysis (Figure 1c) . A unique transcript of 2.4 kb syntenin mRNA was detected and elevated in all of the tumor tissues tested as compared with their normal counterpart. These results led us to make a hypothesis that the overexpression of syntenin could in¯uence the invasive and metastatic potential of human breast and gastric cancer cell lines.
Forced expression of syntenin to MCF7 and Az521 cells stimulates cell migration and invasion
To test this hypothesis, MCF7 cells were transfected with a FLAG-tagged expression vector containing the human syntenin or with the vector alone. After selection in G418, the pooled population of G418-resistant syntenin-transfected MCF7 cells was obtained and designated MCF/mass. Two independent clones were also obtained from MCF/mass by a limiting dilution, designated clone 1 and clone 3. To rule out the clonal variation of MCF7 cells, we mainly used MCF/mass for further experiments. The protein expression of exogenous syntenin in syntenin-transfected MCF7 cells was con®rmed by Western blot analysis using anti-FLAG monoclonal antibody (Figure 2a) , the exogenous syntenin was detected as a single band at 34 kDa in MCF/mass and clone 1, but not in the control and clone 3. The ability of syntenintransfectants cells to migrate through porous ®lters in response to a chemotactic stimulus was examined using a Transwell migration assay. MCF/mass and clone 1 exhibited increased cell migration through ®lters as compared parental MCF7 and neo-MCF7 ( Figure 2b ). The extent of migrated cells was 3.7-and 2.3-fold higher for MCF/mass and clone 1, respectively, as compared with the neo-MCF7 (P50.01, one-way ANOVA). Clone 3, which did not express exogenous syntenin, migrated through ®lters comparable with the control. Similar results were obtained from invasion assay using Matrigel-coated ®lters ( Figure 2c ). MCF/ mass and clone 1 showed signi®cantly increased invasiveness over that of the vector-transfected control (P50.01, one-way ANOVA). The expression level of syntenin was correlated with the number of invaded cells. In migration assay, however, clone 1 showed decreased migratory potential as compared with MCF/ mass despite the high expression level of exogenous syntenin. This could be caused by clonal variation.
To examine whether syntenin also stimulates the migratory potentials of gastric cancer cells, we made stable transfectants of syntenin in Az521 and investigated the eect of syntenin on the migration and invasion of the cells (Figure 3 ). Az521 cells were transfected with a FLAG-tagged syntenin expression vector or with the vector alone. After selection in G418, the pooled population of G418-resistant syntenin-transfected Az521 cells was obtained and designated Az521/mass. The overexpression of syntenin in Az521 cells exhibited increased migration as compared (Figure 3b , P50.01, one-way ANOVA). Similarly, Az521/mass exhibited signi®cant increase of invasiveness over that of the control. The extent of invaded cells was 1.8-fold higher than that of the control (Figure 3c , P50.01, one-way ANOVA). Taken together, these results suggested that syntenin could be one of genes for responsible for the metastatic progression of human breast and gastric cancer cells.
Overexpression of syntenin to MCF7 cells stimulates pseudopodia formation
Since modulation of cytoskeleton proteins has been linked with cell motility, we next investigated the eect of syntenin on F-actin reorganization in MCF7 cells. The cell shape change on type I collagen-coated slide glass of MCF/mass and the control cells were assessed by staining with¯uorescent-conjugated phalloidin, a probe speci®c for F-actin. MCF/mass exhibited the more polarized distribution of F-actin with pseudopodia formation as compared with MCF7 and neo-MCF7 cells (Figure 4) . The ratios of pseudopodia forming morphological changes with pseudopodia formation (data not shown). These results suggested that PDZ2 domain of syntenin could be responsible for its stimulatory eect on cell migration.
Discussion
Several dierent approaches utilizing various methods have been undertaken to compare and identify gene expression related with the metastatic progression of human cancer cells. In this study, SSH was employed to identify dierentially expressed genes during the metastatic progression of human cancer cells using the two human breast cancer cells, MDA-MB-435 and MCF7. Sequence analysis of subtracted cDNA fragments revealed that the number of genes overexpressed in the MCF7 and MDA-MB-435 cells was 9 and 8, respectively. The expression pattern of each of these genes was con®rmed by Northern blot analysis (Table  1) . Seven of them have been previously reported as displaying functional relationships with the metastatic progression of human breast cancer cells. In this ®rst report of its being overexpressed in metastatic cancer cells we also identi®ed syntenin as an overexpressed gene in MDA-MD-435 cells. Therefore, we continued the investigation into the possible role of syntenin in tumor progression.
In this regard, we demonstrated that the expression pattern of syntenin was correlated with the invasive and metastatic potential of various human breast and gastric cancer cell lines (Figure 1) . Furthermore, we provided evidence for the direct role of syntenin in cell migration and invasion by constructing the stable transfectants of the syntenin-overexpressing MCF7 and Az521 cells (Figures 2 and 3) . We also showed that the expression of syntenin was higher in gastric tumor tissues than their normal counterpart ( Figure  1c ). These ®ndings have potential implications for syntenin with respect to its role in the invasive and metastatic progression of human breast and gastric cancer cells.
The acquisition of tumor cell invasiveness is an important aspect of tumor progression and a principal contributing factor to cancer morbidity and mortality. For tissue invasion a tumor cell must ®rst recognize and interact with the surrounding extracellular matrix. Secondly, it must degrade or remodel the surrounding extracellular matrix in order to achieve the important third step: the actual migration of tumor cells through the dissolved extracellular matrix to reach adjacent tissue. Recent reports have indicated that this third, migration step, is a critical rate-limiting step in invasion (Hanahan and Weinberg, 2000; Kassis et al., 2001) . The overexpression of syntenin to MCF7 and Az521 cells promotes the migration and invasion of the cells. We did not observe any signi®cant dierences between syntenin transfectants and the control in terms of adhesion to ®bronectin, type I collagen and laminin (data not shown). Moreover, syntenin transfectants did not alter the expression of matrix metalloproteinases such as MMP-2 and -9, or the proteolytic activities as assessed by gelatin zymography (data not shown). Therefore, it is likely that syntenin may promote the invasiveness of cancer cells by increasing their migratory activity.
While we con®rmed that syntenin stimulates the migratory activity of breast and gastric cancer cell lines, the issue of how syntenin actually promotes cell migration remained to be determined. A previous report showed that the transfection of syntenin to Chinese hamster ovary cells changed the cell morphology to often large,¯at, vesiculated, and decorated with numerous membrane extensions (Grootjans et al., 1997) . Consistent with this result, the stable transfection of syntenin to MCF7 cells was associated with the appearance of numerous membrane extensions and pseudopodia on type I collagen-coated slide glass (Figure 4 ). These observations suggest that syntenin may function as an adaptor able to induce the coupling of membrane proteins to cytoskeletal proteins or to cytosolic downstream signal eectors. Syntenin contains two PDZ domains, which are multifunctional protein-binding modules now found in a growing number of cytoplasmic proteins (Fanning and Anderson, 1999) . Our results indicate that the PDZ2 domain of syntenin might be essential for its stimulatory eect on cell migration ( Figure 5 ).
It has been recognized that the PDZ domains of syntenin interact with several proteins such as syndecans, EphA7 and class B ephrin. The expression of syndecan-1 inversely correlates with metastasis and positively correlates with a more favorable prognosis in several epithelial cancers (Inki and Jalkanen, 1996; Wiksten et al., 2001) . However, it is noteworthy that Eph receptors and ephrin B ligands are expressed in several cancer cell lines and tumor tissues (Tang et al., 1999) and that the expression of ephrin B2 is associated with invasion occurrence in endometrial cancer (Takai et al., 2001) . Moreover, it has been reported that PDZ proteins bind and colocalize with both Eph receptors and their ephrin ligands at neuronal synapses (Torres et al., 1998) and that Eph B-ephrin B signaling plays an essential role in regulating cell migration (Klein, 2001) . Therefore, it will be interesting to investigate whether syntenin plays any role in the cell migration induced by ephrin ligands and their receptors signaling. Also, it is well known that Rho family GTPase both regulates actin cytoskeleton and plays a pivotal role in cell motility (Nobes and Hall, 1995) . In fact, the overexpression of the M92-V298 fragment of syntenin has also been demonstrated to have a strong eect on cell morphology by inducing the formation of long cell projections (Zimmermann et al., 2001) . Interestingly, the morphotype resulting from the overexpression of this syntenin M92-V298 fragment is reversed by the overexpression of constitutively active Rho A mutants (Zimmermann et al., 2001 ). Therefore, it is possible that syntenin, either directly or indirectly, aects Rho family GTPase activity. We are presently exploring this possibility as well as this PDZ2 domain-interacting protein using yeast two-hybrid system.
A recent report has revealed that although the expression of syntenin in fetal tissue is abundant in the kidney, liver, lung, and brain, a much lower level has been detected in all adult tissues except the heart and placenta (Zimmermann et al., 2001) . In the present study, syntenin expression level was elevated in invasive and metastatic human breast and gastric cancer cell lines relative to the level in poorly metastatic ones. Moreover, syntenin expression level was elevated in gastric tumor tissues as compared with their normal counterpart (Figure 1c) , even though the expression of syntenin in gastric tumor tissue with respect to aggressiveness was not analysed in detail. A detailed analysis of syntenin expression in human breast and gastric tumor tissues could lead to an enhancement of our understanding of the potential role played by syntenin in cancer progression and may provide a suitable marker for invasive tumors.
Taken all together, our results indicate that syntenin can/may induce migration and cytoskeletal changes in human breast and gastric cancer cell lines and suggest a potential role for syntenin in the processes of tumor cell migration, invasion, and possibly metastasis. Further study to evaluate the functions and regulation mechanism of syntenin will expand our understanding of the role played by syntenin in tumor progression and may provide a future target for therapy.
Materials and methods
Cell lines
The breast cancer cell lines MDA-MB-435, MDA-MB-231, MDA-MB-468, MDA-MB-453 and Hs578T were maintained in Dulbecco's Modi®ed Eagle Medium (DMEM) (Gibco ± BRL, Rockville, MD, USA); MCF7 and T47D were maintained in RPMI 1640 (Gibco ± BRL). The gastric cancer cell lines and Az521 were obtained from Korean Cell Line Bank of the Cancer Research Center, Seoul National University College of Medicine and maintained in RPMI 1640. The characteristics of these cell lines were described previously (Park et al., 1990 (Park et al., , 1997 . All Media were supplemented with 10% fetal bovine serum, penicillin, and streptomycin and all cell lines were maintained in a humidi®ed 5% CO 2 atmosphere at 378C.
Suppression subtractive hybridization (SSH) and differential screening
Poly(A) + -enriched RNA was isolated using the FastTrack 1 Kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. SSH was performed between MDA-MB-435 and MCF7 using the PCR-Select TM cDNA Subtraction Kit (Clontech, Palo, CA, USA) as described by the manufacturer. Brie¯y, the ®rst-strand cDNA was synthesized with 2 mg of each cell line's mRNA. To identify the metastasis-achievable genes, MDA-MB-435 cDNA was used as a tester and MCF7 cDNA was used as a driver. Oppositely, MCF7 (tester) and MDA-MB-435 (driver) were used in order to identify the metastasis-suppressible genes. The secondary PCR products of subtracted cDNA fragments were ligated into the pCR2.1 vector (Invitrogen) and transformed in Top10F' cells. The insert-containing colonies were arrayed on a nylon membrane and, followed by dierential screening according to the instructions provided by the manufacturer (Clontech). DNA sequencing was performed by automated means at ABI 3100 DNA analyzer system (Perkin-Elmer, Foster, CA, USA). Nucleic acid homology searches were performed in the Genbank using the BLAST program.
Northern blotting
Total RNAs from the various cell lines were extracted using the RNeasy Mini kit (Qiagen, Valencia, CA, USA). Surgical samples of paired normal and tumor tissues were collected from patients undergoing gastric cancer surgery at the Department of Surgery, Konyang University Hospital. Total RNAs from the surgical samples were isolated using the RNAzol TM B (TEL-TEST, Freindswood, TX, USA). Twenty mg of total RNA or 2 mg of poly(A) + RNA were electrophoresed in a 1% agarose-formaldehyde gels and transferred to nylon membranes (Roche, Mannheim, Germany). To detect mRNA expression of the other subtracted genes, inserts were excised from pCR2.1 vector by EcoRI digestion, and used for probes. To detect syntenin, a 376 bp EcoRI ± PstI fragment (from bp 453 to 829 in open reading frame) was labeled with a-32 P-dCTP by random priming method and hybridized with the membrane. Following hybridization, the membrane was washed and exposed on ®lm with an intensifying screen at 7808C.
Construction of various syntenin expression vectors and transfection
To obtain the syntenin cDNA, polymerase chain reaction (PCR) was performed with MDA-MB-435 cDNA as a template and Pfu DNA polymerase (Stratagene, La Jolla, CA, USA). Speci®c primers for syntenin were designed based on the previous sequence (Genbank accession number AF000652); sense 5'-GTGGGCTAGAAGAATCCTGC-3' and antisense 5'-ACTGTTCTGGGCTAGTGTAC-3'. After an initial denaturation step at 958C for 2 min, syntenin was ampli®ed for 30 cycles of 30 s at 948C; 1 min at 558C; 3 min at 728C. Five kinds of syntenin mutants were generated from syntenin cDNA as a template using the following primer sets; N-term (M1-E114): sense 5'-CTTGTGGGCTAGAAGGA-TCCTGCA-3'; antisense 5'-CCTTACACAACTCGAGTTC-ACGAATCCC-3'.
PDZ1 (R113-R193): sense 5'-GCAGAAA-TTAAGCAAG-GATCCGTGAAGTC-3'; antisense 5'-AATC-GTCCGTTC-CTCGAGCCTGTCACGAA-3'.
PDZ2+C-term (P194-V298): sense 5'-TTACCATGACCA-TTCGGGATCCGCCCTT-3'; antisense 5'-TCCATGGTGC-CTCGAGTTTTAAACCTC-3'.
N-term+PDZ1+PDZ2 (M1-I274): sense 5'-CTTGTGGG-CTAGAAGGATCCTGCA-3'; antisense 5'-TATGCTCGAG-GATAAAAGCAGGC-3'.
PDZ2 (P194-I274): sense 5'-TTACCATGACCATTCGG-GATCCGCCCTT-3'; antisense 5'-TATGCTCGAGGATAA-AAGCAGGC-3'.
An amino-terminally FLAG-tagged syntenin or syntenin mutants expression vectors was generated by cloning syntenin or syntenin mutants cDNA into pCMV-Tag 2 (Stratagene) vector with in frame. All sequences were veri®ed by DNA sequencing.
MCF7 and Az521 cells were transfected with the Tag 2-FLAG-syntenin or syntenin mutants using the Lipofectamine Plus (Gibco ± BRL). Forty-eight hours after transfection, the medium was changed with the culture medium supplemented with 750 mg/ml of G418 for selection of stable transfectants. A limiting dilution was performed to obtain several synteninexpressing clones.
Western blotting
Cells were washed with ice-cold PBS (calcium and magnesium-free phosphate buered saline) for three times and extracted in 0.2 ml of ice-cold lysis buer (50 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 1 mM EDTA, 1 mM phenylmethyl sulfonyl¯uoride, 1 mg/ml leupeptin, 150 mM NaCl). An aliquot of lysate was used to determine protein concentration by the Bradford method (Bradford, 1976) . Fifty mg of protein per lane was separated onto 10% SDS-polyacrylamide gel and transferred a PVDF membrane (Millipore, Bedford, MA, USA). The membrane was blocked with 5% skim milk for 3 h, and then incubated for 2 h with anti-FLAG M2 monoclonal antibody (Sigma, St. Louis, MI, USA) or antisyntenin polyclonal antibody (Synaptic Systems, GoÈ ttingen, Germany). After washing, the membrane was incubated with the secondary antibody conjugated with horseradish peroxidase. The signal was detected using the Amersham ECL system (Amersham Pharmacia Biotech, Buckinghamshire, UK). To show the equal loading of protein, the membranes were stripped and reprobed with anti-tubulin antibody (InnoGenex, San Ramon, CA, USA).
Cell migration and invasion assay
The ability of cells to migrate through non-coated (migration) or invade through 10 mg Matrigel-coated ®lters (invasion) was measured with a modi®ed Boyden chamber (Corning Costar, Cambridge, MA, USA; 8 mm pore size). For invasion assay, the lower surface of the ®lters was coated with 6.5 mg ®bronectin as a chemoattractant (Youngs et al., 1997; Cos et al., 1998) .
MCF7 and syntenin-expressing MCF7 cells were seeded at a density of 3610 5 cells in 100 ml RPMI containing 0.5% BSA (migration) or RPMI containing 10% FBS (invasion) in the upper compartment of transwell. Az-521, syntenin or each syntenin mutant-expressing Az-521 cells were seeded at a density of 5610 4 cells. The lower compartment was added 800 ml of RPMI containing 10% FBS.
After incubation for 1 day at 378C in 5% CO 2 the cells that did not penetrate the ®lter were completely wiped out with a cotton swabs, and the cells that had migrated to the lower surface of the ®lter were ®xed with methanol. In invasion assay of MCF7 cells, the cells were incubated for 4 days. And then the cells were stained with hematoxylin and eosin (Sigma), and counted in ®ve randomly selected microscopic ®elds (1006) per ®lter. Three independent experiments were performed for each experimental condition each times. The data were represented as the average of the three independent experiments with the standard error of the average indicated. Statistical comparison was made using one-way ANOVA. P values 50.01 were considered very signi®cant.
Immunofluorescence
Cells were grown on type I collagen-coated slide glass in 10% FBS-RPMI for 20 h, then washed and ®xed with 3.7% paraformaldehyde. And then F-actin was stained with the Alexa Fluor 488 Phalloidin (Molecular Probes, Eugene, OR, USA) as described by the manufacturer. Cells were viewed using a Zeiss microscope with the appropriate ®lters and captured using Axiovision 2.0.
